Articles Tagged With: COVID-19
-
Two Possible Mechanisms of Disease in COVID-19
COVID-19 infection may be associated with an increased risk of blood clotting and related thrombotic events, but there are insufficient data to support indiscriminately discontinuing medications that play a critical role in the management of chronic cardiovascular disease.
-
Guillain-Barré, Miller Fisher Syndrome, and Associated Disorders in Patients with COVID-19
As the COVID-19 pandemic spreads around the world, investigators in multiple countries are reporting patients with myriad cranial and peripheral nerve disorders that have some, but not all, features of Guillain-Barré syndrome.
-
The Effect of Coronaviruses on the Central Nervous System
Known coronaviruses can enter the central nervous system by different pathophysiologic mechanisms. Neurological presentations linked to the novel SARS-CoV-2 include encephalopathy, encephalitis, cranial neuropathies, Guillain-Barré syndrome and other neuropathies, and ischemic and hemorrhagic strokes.
-
Neurologic Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China
Neurological symptoms and impairments have been found in one-third of hospitalized patients with COVID-19 from countries that have reported these observations so far. This is a rapidly evolving consequence of SARS-CoV-2 infection.
-
Q&A Part 3: IRBs Learn Positive and Instructional Lessons from Pandemic
IRB experts share the ways in which the pandemic has spurred innovation in their institutions.
-
Q&A Part 1: IRBs Face Their Toughest Challenges with COVID-19
IRB leaders describe the challenges staff faced during the transition to remote working.
-
IRB Pandemic Impact Report
In this question and answer special report, a dozen IRB administrators, directors, chairs, and other leaders from across the United States were asked about their facilities’ experiences during the COVID-19 pandemic’s early weeks.
-
ACS Prepares Surgeons for Resuming Elective Procedures
The COVID-19 pandemic forced many facilities to press pause on regular operations. Now, some are ready to chart a course back toward some sense of normalcy.
-
COVID-19 Changes HIPAA Compliance, But Caution Necessary
The Department of Health and Human Services Office for Civil Rights has issued waivers and notices of enforcement discretion for several issues related to Health Insurance Portability and Accountability Act compliance, but healthcare organizations still must be careful to comply with the privacy law even during the pandemic.
-
Department of Justice Halts Enforcement and Civil Penalties
The Executive Office for United States Attorneys recently announced that because of the COVID-19 pandemic, the U.S. Department of Justice (DOJ) has temporarily halted enforcement actions and the collection of civil penalties. The original period ran through May 31, but DOJ said it may extend the period.